米罗加巴林:一种新的 gabapentinoid 或另一个虚假的黎明?
Thomas J Craig1, Paul Farquhar-Smith
1Department of Anaesthesia and Pain Medicine, The Royal Marsden Hospital, London, UK.
Current opinion in supportive and palliative care
|August 1, 2024
概括
米罗加巴林是一种新型的 gabapentinoid,由于其有针对性的作用,在神经病痛方面显示出理论上的希望. 然而,临床证据是混合的,需要进一步的大型研究来证实其对传统 gabapentinoids 的益处.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 疼痛管理 疼痛管理
背景情况:
- 神经病痛是一种重大的临床挑战.
- 加巴丁类药物通常用于神经病痛.
- 米罗加巴林是一种具有潜在优势的新型 gabapentinoid.
研究的目的:
- 审查关于米罗加巴林治疗神经病痛的现有证据.
- 为了比较米罗加巴林与传统的 gabapentinoids.
- 评估米罗加巴林的疗效和安全性.
主要方法:
- 审查现有的临床研究和证据.
- 分析米罗加巴林的作用机制.
- 药物不良反应和疗效数据的比较.
主要成果:
- 米罗加巴林向电压通路的α2δ-1子单元,可能减少副作用.
- 有证据表明,米罗加巴林在某些神经病痛综合征中可能优于安慰剂.
- 将米罗加巴林与传统 gabapentinoids 进行比较的临床数据显示,关于疗效和副作用概况的结果各不相同.
结论:
- 比起传统的 gabapentinoids,米罗加巴林具有理论上的优势.
- 目前的临床证据对于米罗加巴林的优越性是不确定的.
- 需要进行更大规模的独立研究才能充分评估米罗加巴林的性能.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
157
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
157
Antiepileptic Drugs: GABAergic Pathway Potentiators
363
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
363
Antiepileptic Drugs: Glutamate Antagonists
305
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
305
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
279
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
279
Sedatives and Hypnotics Drugs: Miscellaneous Agents
163
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
163


